Our Mission, Vision & Values
At Sunovion, our team strives to create and add value for patients. We are focused on improving quality of life for people living with neuropsychiatric conditions by advancing scientific innovation and developing novel therapeutic treatments that can transform the course of illness.
Our Mission
By combining our passion for innovation and our desire to create a healthier world, our mission comes to life. This enables us to serve patients, give them a voice in their care, and help them live better lives.
To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide.
Our Vision
What drives our vision is our commitment to patients. Led by our diverse team of innovators, doers, and makers - all united in the goal of working together to create the best solutions to serve patients and health care partners.
Lead the way to a healthier world.
Our Values
Our values are truly the core of who we are. They inspire our vision, empower our mission, and closely connect us to our community, patients, and one another.
At Sunovion, our teams strives to: Serve and create value for patients. Act with the highest standards. Trust and empower our people. Align, collaborate, and win as one team.
Learn how our employees live our values each day.
Our Values
(1:12)
Serve and Create Value for Patients
(0:39)
Act With the Highest Standards
(0:33)
Trust and Empower Our People
(0:37)
Align, Collaborate and Win as One Team
(0:35)
Guided By Purpose
We Believe In...
Empowering the Neuropsychiatric Community
We believe our role is vital in the pursuit of better outcomes, better support, and better overall wellness. For those experiencing the impact of CNS disorders, we have a responsibility to help.
Developing a Pipeline of Innovative Therapies
Our passion for innovation drives our pipeline, where we have numerous investigational treatments to meet the demands of neuropsychiatric patients.
Delivering Novel Treatments for Serious CNS Conditions
Our track record for innovative and effective therapies has transformed the lives of patients around the world.
Acting with Compassion, Empathy, and Responsibility
Sunovion is committed to serving our local, regional, and global community. As part of our Corporate Social Responsibility efforts, we depend on collaboration and partnership to build stronger, healthier communities.
Putting Patients First
Our most important relationship is the one we have with the patients we serve. Whether it’s through our patient support efforts or advocacy, we embrace our vision of building a healthier world.
Our People
and Culture
Therapies in Development
Uncover our latest developments as we continue to expand our portfolio of CNS treatments.
| Therapeutic Area | Candidate | Indication/Target | Phase |
|---|---|---|---|
| Psychiatry | Ulotaront (SEP-363856) | Schizophrenia | Phase 3 75% complete |
| Psychiatry | SEP-4199 | Bipolar depression | Phase 3 75% complete |
| Psychiatry | Ulotaront (SEP-363856) | Adjunctive major depressive disorder | Phase 3 75% complete |
| Therapeutic Area | Candidate |
|---|---|
| Indication/Target | |
| Psychiatry | Ulotaront (SEP-363856) |
| Schizophrenia | |
Phase 3 75% complete | |
| Psychiatry | SEP-4199 |
| Bipolar depression | |
Phase 3 75% complete | |
| Psychiatry | Ulotaront (SEP-363856) |
| Adjunctive major depressive disorder | |
Phase 3 75% complete | |
